IMMUNE FUNCTION PARAMETERS AT DIAGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - CORRELATION WITH THE FAB CLASSIFICATION AND PROGNOSIS

被引:0
|
作者
SYMEONIDIS, A
KOURAKLI, A
KATEVAS, P
PERRAKI, M
TINIAKOU, M
MATSOUKA, P
GEORGOULIAS, V
ZOUMBOS, N
机构
[1] UNIV PATRAS,SCH MED,DEPT INTERNAL MED,DIV HAEMATOL,BOX 1045,GR-26110 PATRAS,GREECE
[2] UNIV PATRAS,IMMUNOHAEMATOL LAB,PATRAS,GREECE
关键词
MYELODYSPLASIA; IMMUNE ABNORMALITIES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We determined nine immune function parameters at diagnosis in patients with myelodysplastic syndromes (MDS) and correlated the results with the FAB classification and prognosis by univariate and multivariate analyses. Patients with refractory anaemia (RA) and refractory anaemia with ring sideroblasts (RAS) tended to have a higher CD4/CD8 ratio and a lower amount of gamma-globulins and soluble interleukin-2 receptors in serum in comparison to those suffering from the other three subgroups of MDS. FAB classification, neutrophil and CD8+ T-cell number had the best discriminatory capacity for predicting survival less than 1 year, and FAB classification, neutrophil number and serum TNF levels were predictors for conversion to acute leukaemia. The frequent occurrence of infections, on the other hand, could be better predicted by the absolute numbers of neutrophils and CD4+ cells and by the skin test score.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 50 条
  • [31] Guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes
    Killick, Sally B.
    Wiseman, Daniel H.
    Quek, Lynn
    Cargo, Catherine
    Culligan, Dominic
    Enright, Helen
    Green, Simone
    Ingram, Wendy
    Jones, Gail L.
    Kell, Jonathan
    Krishnamurthy, Pramila
    Kulasekararaj, Austin
    Mills, Juliet
    Mufti, Ghulam
    Payne, Elspeth M.
    Raghavan, Manoj
    Stanworth, Simon J.
    Sternberg, Alex
    Bowen, David
    Haematology, British Society For
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (02) : 282 - 293
  • [33] Commentary on "Clinical Presentation, Diagnosis, and Prognosis of Myelodysplastic Syndromes"
    Repasy, Andrew
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (07): : S14 - S14
  • [34] Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis
    Stetler-Stevenson, M.
    Yuan, C. M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2009, 31 (05) : 479 - 483
  • [35] Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
    Kasprzak, Annika
    Nachtkamp, Kathrin
    Gattermann, Norbert
    Germing, Ulrich
    CANCERS, 2022, 14 (08)
  • [36] Clinical features and prognosis of patients with myelodysplastic syndromes
    Germing, Ulrich
    Strupp, Corinna
    Giagounidis, Aristoteles
    CANCER TREATMENT REVIEWS, 2007, 33 : S15 - S18
  • [37] UTILITY OF THE FAB CLASSIFICATION FOR MYELODYSPLASTIC SYNDROMES - INVESTIGATION OF PROGNOSTIC FACTORS IN 237 CASES
    KERKHOFS, H
    HERMANS, J
    HAAK, HL
    LEEKSMA, CHW
    BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (01) : 73 - 81
  • [38] Diagnosis of Myelodysplastic Syndromes in Cytopenic Patients
    Wang, Sa A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (05) : 1085 - +
  • [39] Myelodysplastic syndromes according to FAB and WHO classification. Single center experience
    Haus, O
    Kotlarek-Haus, S
    Potoczek, S
    Czarnecka, M
    Duszenko, E
    Makowska, I
    Mirowska, N
    Kuliczkowski, K
    NEOPLASMA, 2006, 53 (02) : 136 - 143
  • [40] RETROSPECTIVE FAB CLASSIFICATION OF 30 PATIENTS WITH MYELODYSPLASTIC SYNDROME
    PIGUET, D
    SCHMIDT, PM
    DELACRETAZ, F
    MERMILLOD, B
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 117 (02) : 61 - 66